Profile

Mediphage has developed a proprietary and scalable E. coli-based manufacturing process for the production of ministring DNA (msDNA), a linear covalently closed (LCC), high-fidelity double-stranded DNA minivector. msDNA lends itself to various applications, including starting materials for the production of viral vectors like rAAVs and lentivirus, msRNA, gene therapy, and gene editing.

Mediphage logo

Website

mediphage.ca

Contact


Event details

Date: January 8 - 10, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

18 in total